Table 2.
Frequency | |
---|---|
Side effects/metabolic problems | 80 |
Reluctance to have blood test | 74 |
Lack of experience/knowledge | 71 |
Patient/family reluctance to use clozapine | 60 |
Clinicians concerns about poor compliance | 54 |
Complex to initiate and manage | 42 |
Service fragmentation/no community support | 39 |
Need to admit/bed shortage | 32 |
Tendency to try other antipsychotics first | 28 |
Delayed diagnosis/not sure about diagnosis | 12 |
Negative views of others | 8 |